Literature DB >> 16789020

Recombinant Newcastle Disease virus capsids displaying enterovirus 71 VP1 fragment induce a strong immune response in rabbits.

Lalita Ambigai Sivasamugham1, Mary Jane Cardosa, Wen Siang Tan, Khatijah Yusoff.   

Abstract

The complete VP1 protein of EV71 was truncated into six segments and fused to the C-terminal ends of full-length nucleocapsid protein (NPfl) and truncated NP (NPt; lacks 20% amino acid residues from its C-terminal end) of newcastle disease virus (NDV). Western blot analysis using anti-VP1 rabbit serum showed that the N-terminal region of the VP1 protein contains a major antigenic region. The recombinant proteins carrying the truncated VP1 protein, VP1(1-100), were expressed most efficiently in Escherichia coli as determined by Western blot analysis. Electron microscopic analysis of the purified recombinant protein, NPt-VP(1-100) revealed that it predominantly self-assembled into intact ring-like structures whereas NPfl-VP(1-100) recombinant proteins showed disrupted ring-like formations. Rabbits immunized with the purified NPt-VP(1-100) and NPfl-VP(1-100) exhibited a strong immune response against the complete VP1 protein. The antisera of these recombinant proteins also reacted positively with authentic enterovirus 71 and the closely related Coxsackievirus A16 when analyzed by an immunofluorescence assay suggesting their potential as immunological reagents for the detection of anti-enterovirus 71 antibodies in serum samples. 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16789020     DOI: 10.1002/jmv.20668

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  14 in total

1.  Monoclonal neutralizing antibodies against EV71 screened from mice immunized with yeast-produced virus-like particles.

Authors:  Tao Lin; Lingzhi Xianyu; Songya Lyu
Journal:  Virol Sin       Date:  2015-05-29       Impact factor: 4.327

Review 2.  Therapeutic and prevention strategies against human enterovirus 71 infection.

Authors:  Chee Choy Kok
Journal:  World J Virol       Date:  2015-05-12

3.  Highly attenuated Bordetella pertussis strain BPZE1 as a potential live vehicle for delivery of heterologous vaccine candidates.

Authors:  Si Ying Ho; Shi Qian Chua; Damian G W Foo; Camille Locht; Vincent T Chow; Chit Laa Poh; Sylvie Alonso
Journal:  Infect Immun       Date:  2007-10-22       Impact factor: 3.441

4.  The cross-reactivity of the enterovirus 71 to human brain tissue and identification of the cross-reactivity related fragments.

Authors:  Chun Shi Jia; Jiang Ning Liu; Wan Bo Li; Chun Mei Ma; Shu Zhu Lin; Yi Hao; Xue Zhong Gao; Xiao Lin Liu; Yan Feng Xu; Lian Feng Zhang; Chuan Qin
Journal:  Virol J       Date:  2010-02-22       Impact factor: 4.099

5.  Immunization with recombinant enterovirus 71 viral capsid protein 1 fragment stimulated antibody responses in hamsters.

Authors:  Wei-Choong Ch'ng; Eric J Stanbridge; Kum-Thong Wong; Kien-Chai Ong; Khatijah Yusoff; Norazizah Shafee
Journal:  Virol J       Date:  2012-08-09       Impact factor: 4.099

6.  Comparative analysis of the immunogenicity and protective effects of inactivated EV71 vaccines in mice.

Authors:  Qunying Mao; Chenghong Dong; Xiuling Li; Qiang Gao; Zengbing Guo; Xin Yao; Yiping Wang; Fan Gao; Fengxiang Li; Miao Xu; Weidong Yin; Qihan Li; Xinliang Shen; Zhenglun Liang; Junzhi Wang
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

7.  Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system.

Authors:  Chia-Chyi Liu; Meng-Shin Guo; Fion Hsiao-Yu Lin; Kuang-Nan Hsiao; Kate Hsuen-Wen Chang; Ai-Hsiang Chou; Yu-Chao Wang; Yu-Ching Chen; Chung-Shi Yang; Pele Choi-Sing Chong
Journal:  PLoS One       Date:  2011-05-13       Impact factor: 3.240

8.  Genetic diversity and C2-like subgenogroup strains of enterovirus 71, Taiwan, 2008.

Authors:  Yuan-Pin Huang; Tsuey-Li Lin; Li-Ching Hsu; Yu-Ju Chen; Yin-Hsin Tseng; Chiu-Chu Hsu; Wen-Bin Fan; Jyh-Yuan Yang; Feng-Yee Chang; Ho-Sheng Wu
Journal:  Virol J       Date:  2010-10-20       Impact factor: 4.099

9.  Display of VP1 on the surface of baculovirus and its immunogenicity against heterologous human enterovirus 71 strains in mice.

Authors:  Tao Meng; Annasaheb B Kolpe; Tanja K Kiener; Vincent T K Chow; Jimmy Kwang
Journal:  PLoS One       Date:  2011-07-01       Impact factor: 3.240

10.  Immunological and biochemical characterization of coxsackie virus A16 viral particles.

Authors:  Pele Chong; Meng-Shin Guo; Fion Hsiao-Yu Lin; Kuang-Nan Hsiao; Shu-Yang Weng; Ai-Hsiang Chou; Jen-Ren Wang; Shih-Yang Hsieh; Ih-Jen Su; Chia-Chyi Liu
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.